Marksans Pharma has informed that it enclosed a Press Release dated June 01, 2026 titled ‘Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets’. Enclosed details required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/ 4/2015 dated September 9, 2015 given in Annexure A to this letter.
The above information is a part of company’s filings submitted to BSE.